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Protein kinase inhibitorDeath associated protein kinase (DAPK) is a calmodulin (CaM)-regulated protein kinase that is a therapeutic
target for central nervous system (CNS) disorders. We report here the results of studies that test the
hypothesis of McNamara et al. (2009) that conformational selection in DAPK's glycine-rich region is key for
catalytic activity. The hypothesis was tested by site-directed mutagenesis of glutamine-23 (Q23) in the
middle of this loop. The glycine-rich loop exhibits localized differences in structure among DAPK
conformations that correlate with different stages of the catalytic cycle. Changing the Q23 to a Valine
(V23), found at the corresponding position in another CaM regulated protein kinase, results in a reduced
catalytic efﬁciency. High resolution X-ray crystal structures of various conformations of the Q23V mutant
DAPK and their superimposition with the corresponding conformations from wild type catalytic domain
reveal localized changes in the glycine-rich region. The effect of the mutation on DAPK catalytic activity and
the ﬁnding of only localized changes in the DAPK structure provide experimental evidence implicating
conformational selection in this domain with activity. This article is part of a Special Issue entitled: 11th
European Symposium on Calcium.opean Symposium on Calcium.
m-Tokars).
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Protein kinases are macromolecular catalysts that serve critical
intracellular signal transduction roles in eukaryotic cells. The rate-
limiting step in the catalytic cycle of a signaling protein kinase is the
release of the products, ADP and the phosphorylated protein product.
There is a rapidly increasing knowledge over the past few years about
the comparative differences in structures of kinases representative of
the various catalytic cycle stages. This includes comparative changes
among kinases complexed with ADP, a reaction product, and non-
hydrolysable analogs of ATP, a reaction substrate. The high resolution
structures of different conformational states of various kinases have
provided insight into how kinase structuremight be related to the stage
of the catalytic cycle. In this regard, we recently [1] determined and
analyzed the structures of various conformations of the calmodulin
(CaM) regulated protein kinase, death associated protein kinase
(DAPK), in attempts to gain insight into how this particular kinase's
structure is altered with various states containing bound substrate
analog or reaction product as well as the apoenzyme. Superimposition
revealed localized changes in the glycine-rich region, sometimes calledthe P-loop, that correlated with more open or closed conformations of
the glycine-rich region centered around glutamine-23 (Q23).
The emergent hypothesis from the work of McNamara et al. [1] was
that theportionof the glycine-rich regionaroundQ23maybe essential for
interaction with ATP and ADP, making it important in catalytic activity.
This report directly addresses this hypothesis through the use of site-
directed mutagenesis of Q23 to a valine (V23) found in another CaM
regulated protein kinase, analysis of the activity of themutant kinase, and
comparison of the differences in selected conformational states of the
mutant kinase. These results are consistent with the hypothesis of
McNamara et al. [1]. Further, the analyses raise the possibility that
targeting the conformation of this particular region of DAPK may prove
fruitful for the identiﬁcation of novel inhibitors that couldwork indirectly
by modulating the conformational state of DAPK in this region.
The interest in DAPK as a central nervous system (CNS) drug
discovery target is based on the in vivo role of DAPK in animal model
disease progression that is dependent on the kinase domain's catalytic
activity [2–6]. Bioavailable DAPK inhibitors administered during
clinically relevant therapeutic time windows attenuate synaptic
dysfunction and improve longer term neurological outcomes. More
recent clinical data [7] has mapped an age-onset AD susceptibility locus
to theDAPKgene. Therefore, there is an increasing bodyof evidence that
links the DAPK catalytic activity to disease progression and its
attenuation via use of bioavailable small molecule inhibitors of activity.
The interest in DAPK catalytic domain activity from a potential CNS
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testing of the hypothesis of McNamara et al. [1] about the glycine-rich
region.
2. Materials and methods
2.1. Generation of DAPKQ23V mutant
The DAPKQ23V mutant was created in the pASK-IBA-3 expression
vector (Sigma-GenoSys) using the Quik Change Site-Directed Muta-
genesis Kit (Stratagene). Themutagenesis procedures and construct has
been previously described in Velentza et al. [8]. The mutation was
conﬁrmed byDNA sequence analysis using the vector speciﬁc primer 5'-
GAGTTATTTTACCACTCCCT-3' and an ABI 3730 DNA Sequencer with Big
Dye v.3.1. The plasmidswere transformed into XL1-Blue Escherichia coli.
2.2. Protein production of DAPK and DAPKQ23V
The constitutively active catalytic domain consisting of amino
acids 1–285 of DAPK and DAPKQ23V were expressed and puriﬁed as
previously described [8]. For crystallization trials of enzyme in
complex with Mg2+ and ADP or AMPPNP, the anion exchange
chromatographic step, which included the use of EDTA [8], was
eliminated from the puriﬁcation protocol. As described in McNamara
et al. [1], the cells were sonicated in a buffer consisting of 100 mM
Tris–HCl, pH 8.0, 0.25 M NaCl, 0.7 mg/L pepstatin A, 0.01% Triton X-
100, and 1 mMDTT. After concentration, the buffer for the proteinwas
exchanged into 20 mM Tris–HCl pH 8.0 and 0.25 M NaCl.
2.3. Activity assays
Enzyme assays and kinetic analyses were done as previously
described [8]. Brieﬂy, concentrations of the peptide substrate from
2.5 μM–50 μM were incubated with 200 μM ATP and [γ-32P]-ATP
(2.5 μCi per reaction) in assay buffer (50 mM Hepes, pH 7.5, 1 mM
DTT, 5 mM MgCl2, 150 mM KCl, 15 mM NaCl) for 12 min at 25 °C
either with or without the DAPK catalytic domain. Peptide 38
(KKRPQRRYSNVF) from the DAPK peptide substrate discovery studies
was used for the kinetics determination [8]. Reactions were initiated
by the addition of the DAPK catalytic domain. Reaction mixture
aliquots were spotted onto P-81 paper (Whatman, Clifton, NJ),
washed with 75 mM H3PO4 and 95% ethanol, and quantiﬁed by
scintillation counting in EcoScint O (National Diagnostics, Atlanta,
GA). Less than 10% of the peptide was consumed under these
conditions. Kinetic data were analyzed by nonlinear regression curve
ﬁtting, using the Michaelis–Menten equation (Prism version 4.0,
GraphPad Software, Inc.). Catalytic efﬁciency was calculated as the
kcat/Km. For ATP kinetics, the same procedure was used except the
peptide concentration was held constant at 5× the Km of the peptide
substrate with varying concentrations of ATP from 1 μM–25 μM.
2.4. Crystallization, data collection, and structure determination
For the complexes of DAPKQ23Vwith nucleotides, a protein solution
at 5.5 mg/mL in 20 mMTris pH8.0, 1 mMDTT, 1 mMEDTA, 0.25 MNaCl
was incubated with 1 mM of either AMPPNP or ADP at 4 °C. Incubation
times of nucleotide and protein varied from 30 min to 24 h. Crystalli-
zation conditions were determined using the 96-well plate NeXtal
AmSO4 suite screen (Qiagen, Valencia, CA) using the sitting drop
method for crystallization. Crystallization plates were incubated at
295 K and crystals appeared within 15 h. Crystals were harvested
directly from the 96-well plate and were ﬂash frozen in cryoprotection
solvent that consisted of the mother liquor supplemented with 30%
sucrose and 3.8 mM of either ADP or AMPPNP. Structures which
contained Mg2+ were also preincubated with 10 mM MgCl2 and the
cryoprotection solution contained 50 mMMgCl2.Data setswere integrated andmerged usingHKL2000 [9]. Structures
were determined by molecular replacement using MolRep [10] using
the original DAPK model [11] (PDB ID: 1JKS) with waters removed.
Interactive rounds of model building with Coot [12], reﬁnement with
Refmac5 [13], and solvent addition with ARP/wARP [14] led to the ﬁnal
reﬁned model. Superpositions of protein structures were done using
Least Squares Fitting (LSQ) within Coot using all atoms. Figures were
prepared with Pymol [15]. The coordinates of DAPKQ23V-AMPPNP,
DAPKQ23V-ADP, DAPKQ23V-AMPPNP-Mg2+, DAPKQ23V-ADP-Mg2+,
DAPKQ23K, and DAPKQ23K-AMPPNP have been deposited in the PDB
(3GU4, 3GU6, 3GU5, 3GU7, 3DGK, and 3DFC, respectively).
3. Results
3.1. Rationale and design
DAPK is a member of the calmodulin regulated protein kinases
(CaMKs), intracellular enzymes whose activity is modulated by
intracellular calcium signaling via their respective calmodulin (CaM)
regulatory subunits. Of the greater than 30 CaMKs known, DAPK and
two other CaM regulated protein kinases, myosin light chain kinase
(MLCK), and phosphorylase kinase (PhosK), are especially interesting
due their restrictive substrate preferences compared to other CaMKs
that are more promiscuous in their phosphorylation of numerous and
diverse protein substrates [16]. A sequence alignment of the kinase
domain from human DAPK,MLCK and PhosK is presented in Fig. 1a and
highlights common features of the enzymes. This information has been
mapped onto a three-dimensional representation of the conserved core
of the catalytic domain (PDB ID: 3F5G), represented in Fig. 1b. The
domain arrangement consists of a smaller N-terminal domain that is
predominantly β-sheet, and a larger C-terminal domain containing
mostlyα-helices, which are connected by a hinge region. A glycine-rich
region involved in hydrogen bonding to nucleotide phosphates of ATP
[1] contains residues found in close proximity to the proposed peptide
substrate recognition regions of protein kinases [8].
Previous studies on DAPK raised the possibility that the glycine-
rich loop region might be key for catalytic activity and identiﬁed the
region around Q23 as especially attractive [1]. We directly tested this
possibility by introducing a site-directed mutant at this position. This
residue corresponds to a valine and a lysine in PhosK and MLCK,
respectively. By mutating this position to a closely related kinase, we
sought to elicit a localized change in the loop region without
perturbing the overall structure. We chose to begin with a Q23V
mutation, corresponding to the residue of PhosK. Like DAPK, PhosK
lacks the third conserved glycine found in 85% of known kinases [17].
The mutation of Q23 to Val resulted in a DAPK glycine-rich loop
sequence -Leu-Gly-Ser-Gly-Val23-Phe-Ala-Val-Val.
3.2. The mutation of glutamine 23 to valine results in a loss of DAPK
catalytic efﬁciency
The effect of the Q23K point mutation on DAPK catalytic activity is
summarized in Table 1. The mutation resulted in an increase in the Km
for the peptide substrate from 6.8 μM to 14.2 μM,while the Km value for
ATP remained the same. The kcat value determined for both substrates is
reduced bymore than 10-fold in DAPKQ23V compared to the wild type
DAPK. The overall catalytic efﬁciency (kcat/Km) for the enzyme is
reduced from 12.2 μM−1 min−1 to 0.5 μM−1min−1, due primarily to
changes in kcat.
3.3. The crystal structures of DAPKQ23V-AMPPNP and DAPKQ23V-
AMPPNP-Mg2+ and their comparison to wild type complexes
The three-dimensional structures of DAPKQ23V in complex with
AMPPNP and AMPPNP-Mg2+ were determined by X-ray crystallog-
raphy to resolutions of 1.35 and 1.65 Å, respectively. Data collection
Fig. 1. a) Sequence alignment of DAPK, MLCK, and PhosK (NCBI sequences NP_004929, NP_444253, NP_006204). The glycine-rich loop region, catalytic lysine and start of the
activation domain (DRG) are highlighted b) Three dimensional representation of DAPK in the presence of ADP (PDB ID: 3F5G). The glycine-rich region is colored tan, the catalytic
lysine in red and DRG in green.
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− Fc) omit maps (not shown) contoured at the 3.0σ level revealed
electron density for the nucleotides at the expected location, between
the N- and C-terminal domains. The occupancy for the γ-phosphate of
AMPPNP in the DAPKQ23V-AMPPNP-Mg2+ and DAPKQ23V-AMPPNP
structures were adjusted to 0.25 and 0.5 to eliminate negative density.
As was the case for the wild type structure of DAPK-AMPPNP-Mg2+
(PDB ID: 3F5U), one Mg2+ ion is seen in the Q23V-AMPPNP-Mg2+
structure. The Mg2+ ion is coordinated by six ligands, which include
the OD2 Asp 161 (2.1 Å), the OD1 Asn144 (2.6 Å), an HOH (1.6 Å), the
O1A of theα-phosphate (2.1 Å), an HOH (2.1 Å), and the O3G of the γ-
phosphate (2.4 Å). In the DAPK-AMPPNP-Mg2+ structure, the Mg2+ isTable 1
Kinetics for DAPK and DAPKQ23V. Assay conditions are described in Section 2.3.
Protein DAPK DAPKQ23V
Km (μM) peptide 6.8±0.5 14.2±1.0
kcat (min−1)
Peptide 83.3±2.4 7.4±0.4
kcat/Km (μM−1min−1)
Peptide 12.2 0.5
Km (μM) ATP 4.1±0.4 4.4±0.4
kcat (min−1) ATP 83.9±3.9 7.0+0.3
kcat/Km (μM−1min−1) ATP 20.6 1.6coordinated to the O2G of the γ-phosphate rather than the OD1 of
Asn144.
In contrast to the DAPK-AMPPNP-Mg2+ structure, where Q23 and
the adjacent Phenylalanine 24 (F24) appear to have two conforma-
tions each, Valine 23 (V23) in the DAPKQ23V-AMPPNP-Mg2+
structure can be modeled into a single conformation with F24 in the
“up” conformation. In the absence of Mg2+, the DAPKQ23V-AMPNP is
modeled with a single conformation of F24 in the “up” position and
two conformations for V23. A superposition of the DAPKQ23V-
AMPPNP and DAPKQ23V-AMPPNP-Mg2+ structures shows that the
loop region around residue 23 is more closed in the DAPKQ23V-
AMPPNP structure when the second conformation of V23 is
considered.
3.4. The crystal structures of DAPKQ23V-ADP and DAPKQ23V-ADP-Mg2+
and their comparison to wild type complexes
In addition to the AMPPNP structures, DAPKQ23V was solved in
complex with ADP and ADP-Mg2+ at 1.50 Å and 1.90 Å, respectively.
Data collection and reﬁnement statistics are shown in Table 2.
Electron density for the ADP was clearly visible in the mutant
structures in the presence and absence of Mg2+. One Mg2+ ion was
modeled in the structure with an octahedral coordination including
the OD2 of Asp161 (2.2 Å), an HOH (2.5 Å), the O3B of ADP (2.3 Å), an
HOH (2.5 Å), an HOH (1.7 Å), and the O1A ADP (2.2 Å). This differs
Table 2
Crystallographic data collection and reﬁnement statistics for the DAPKQ23V-AMPPNP, DAPKQ23V-AMPPNP-Mg2+, DAPKQ23V-ADP and DAPKQ23V-ADP-Mg2+ structures. All
structures have been deposited in the protein data bank.
DAPKQ23V-AMPPNP DAPKQ23V-AMPPNP-Mg2+ DAPKQ23V-ADP DAPKQ23V-ADP-Mg2+
Ligand AMPPNP AMPPNP-Mg2+ ADP ADP-Mg2+
PDB code
3GU4 3GU5 3GU6 3GU7
Space group P212121
Unit-cell parameter (Å) a=46.9 a=46.9 a=46.9 a=46.89
b=62.4 b=62.5 b=62.3 b=62.4
c=88.4 c=88.6 c=88.1 c=88.3
X-ray source LSCAT-21-ID-F LSCAT-21-ID-G LSCAT-21-ID-G LSCAT-21-ID-G
Wavelength (Å) 0.97872 0.97857 0.97857 0.97857
Resolution (Å) 30.0–1.35(1.40–1.35) 30.0–1.65(1.71–1.65) 30.0–1.50(1.55–1.50) 30.0–1.90(1.97–1.90)
No. of unique reﬂections 57,021 32,180 42,344 21,031
Completeness 98.84(97.33) 99.83(98.11) 99.44(94.30) 99.91(99.48)
Redundancy 5.7(5.6) 7.0(7.0) 7.3(6.9) 6.8(6.9)
Mean I/σ(I) 12.7(3.3) 13.1(4.7) 11.5(3.8) 10.5(4.7)
Rmerge 0.059(0.354) 0.070(0.409) 0.079(0.487) 0.079(0.412)
Final Rwork 0.184(0.207) 0.175(0.204) 0.183(0.218) 0.170(0.185)
Final Rfree 0.211(0.235) 0.219(0.281) 0.213(0.240) 0.228(0.280)
Bond lengths (Å) 0.008 0.012 0.009 0.015
Bond angles () 1.31 1.47 1.31 1.68
Average B-factors (Å) 17.54 20.92 17.9 22.6
Main chain 14.59 18.50 15.61 20.27
Side chain+Solvent 19.77 22.81 19.73 24.56
Ligand 20.10 19.15 28.90 30.95
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OE2 of Glu14 and OD1 of Asn144, rather than waters. There is an
alternative conformation for the β-phosphate in the absence of Mg2+.
The residues at V23 and F24 were modeled in two conformations
for the DAPKQ23V-ADP-Mg2+ and DAPKQ23V-ADP structures. This is
similar to the loop regions of the corresponding wild type ADP
complexes DAPK-ADP-Mg2+ and DAPK-ADP (PDB ID: 3F5G and 3EH9,
respectively). The structures of DAPKQ23V-ADP-Mg2+ and DAPK-Fig. 2. (a) Ligand binding site of DAPK-AMPPNP-Mg2+ (magenta) and DAPKQ23V-
AMPPNP-Mg2+ (green). Included is a superposition of the glycine-rich loop residues 17–
27. (b) Ligand binding site of DAPK-ADP-Mg2+ (magenta) and DAPKQ23V-ADP-Mg2+
(green). Included is a superposition of the glycine-rich loop residues 17–27. Alternate
conformations are shown in these traces.ADP-Mg2+ were superimposed as well on the DAPKQ23V-ADP and
DAPK-ADP structures. Differences were noted in the glycine-rich
region for the overlay of DAPKQ23V-ADP with DAPK-ADP, with an r.
m.s. deviation of 2.56 Å for the Cα atoms of residues 20–25. The r.m.s
deviation value for this region of DAPKQ23V-ADP-Mg2+ and DAPK-
ADP-Mg2+ is 0.83 Å. The superpositions suggest that the mutant
DAPK in complex with ADP has a glycine-rich loop that is more closed
compared to the corresponding wild type structures. The loop closure,
however, is more evident when the non-Mg2+ structures are
compared.3.5. Comparing members of the catalytic cycle
Fig. 2a shows a superposition of DAPK-AMPPNP-Mg2+ and Q23V-
AMPPNP-Mg2+. The DAPK-AMPPNP-Mg2+ complex is shown in
magenta and has two conformations present for residues Q23 and
F24. The Q23V mutant shown in green maintains a single conforma-
tion in the crystal structure. The closed conformation for the wild typeRelease of Products
Rate limiting step
ADP 
Phospho-transfer
(fast)
Substrate
Kinase 
Product
Kinase 
ADP 
Kinase ATP 
Substrate
P 
P 
ATP 
Product
Fig. 3. Kinetic scheme for phosphoryl transfer reaction. The kinase binds two substrates,
ATP and a peptide or protein substrate. Once substrate is bound, the phosphoryl
transfer step proceeds rapidly relative to product release.
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evident with the Q23Vmutant. The bottom panel is a superposition of
DAPK-ADP-Mg2+ and DAPK-Q23V-ADP- Mg2+. The DAPK-ADP-Mg2+
complex shown in magenta displays two conformations for Q23. The
Q23V-ADP- Mg2+ complex has the valine in two orientations as well
as F24. In the crystal structures, the R-group of the Q23V appears to be
pointed away from ADP when Mg2+ is present.4. Discussion
The studies reported here provide a more direct link between
conformations of the glycine-rich region of DAPK and enzyme activity.
As schematically illustrated in Fig. 3, the various conformations of
DAPK with bound substrate or product can be considered reﬂective of
transient states in a catalytic cycle. The protein kinase binds the two
substrates, ATP and protein, and facilitates a phosphoryl transfer
reaction, followed by release of products. The phosphoryl transfer step
is fast, while the release of products is the rate-limiting step [18]. The
demonstration that a point mutation in the glycine-rich region can
result in only localized changes in structure yet diminish catalytic
efﬁciency signiﬁcantly is consistent with the hypothesis that this loop
is a critical modulator of DAPK catalytic activity. As a logical extension
of the results presented here, we also explored the potential impact of
a Q23K mutation corresponding to the closely related MLCK region.
This point mutation was also detrimental to catalytic activity due
mainly to the kcat term (data not shown) and also resulted in only
localized conformational differences (see PDB IDs: 3DFC, 3DGK).
Superimposition of DAPK-AMPPNP (magenta), DAPKQ23V-AMPPNP
(grey), and DAPKQ23K-AMPPNP (cyan) reveal (Fig. 4) a common
trend of a more closed state for the glycine-rich loop in the mutants,
and altered geometry of the nucleotide at the γ-phosphate.
Clearly, the glycine-rich loop region around Q23 plays an
important role in catalysis, but the manner in which this particular
residue contributes to alteration of loop conformation is not as
evident. Results from examination of this corresponding region in
other Ser/Thr protein kinases are consistent with those reported here.
For example, mutagenesis of Ser53 in cAMP-dependent protein kinase
(PKA), corresponding to Q23 of DAPK, resulted in a loss of kinase
activity [19]. Similarly, PhosK, exhibits a loss of activity when V29,
corresponding to Q23, is mutated to a serine [20]. The PhosK-V29S
mutant had an apparent increase in afﬁnity for ADP. It was suggested
[20] that the apparent increase in afﬁnity was due to an altered
conformation leading to binding of the nucleotide product with
greater afﬁnity. Our kinetic and structural results for DAPK Q23
mutant are consistent with such models.Fig. 4. Superposition of the glycine-rich region of DAPK, DAPKQ23V and DAPKQ23K in
complex with AMPPNP. Residues 19–27 are depicted as a carbon backbone trace and
AMPPNP is rendered as a ball and stick model. Wild type DAPK in magenta, DAPKQ23V
in cyan and DAPKQ23K in gray. An alternative conformation is observed for the
AMPPNP γ-phosphate of the Q23 mutants relative to the wild type.The hypothesis derived from the work of McNamara et al. [1] was
that the portion of the glycine-rich region around Q23 may be
essential for interaction with ATP and ADP, making it important in
catalytic activity. The current data presented for the DAPKQ23V
mutant support this hypothesis. A logical extension of the hypothesis
based on the data presented here is that conformational selection
around the glycine-rich region of DAPKmight be a potentialmechanism
for modulating kinase activity. For example, restricting conformational
sampling by this region of DAPK could result in restriction of phosphate
transfer or generation of a more closed conformation. Mechanistically,
the latter could result in a decreased release of product, whereas the
former couldderive from the inability of theQ23 side chain toorient and
stabilize the ligand or from an alteration of the geometry around the
phosphates such that a less than ideal arrangement would be provided
for the phosphoryl transfer.5. Conclusions
The structures reported here are the ﬁrst DAPK mutant structures
and the ﬁrst for any kinase altered in the glycine-rich region.
Structural changes brought about by targeted point mutations are
localized to the loop region that contains the mutation and result in
signiﬁcant changes in catalytic efﬁciency.Acknowledgements
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